The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: A randomized, double-blind, placebo-controlled trial

Journal of Alternative and Complementary Medicine

Volumn 14, Issue 9, 2008, Pages 1137-1144

  Boskabady, Mohammad H ^a,b   Farhadi, Javad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Ghaem Medical School   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; NIGELLA SATIVA EXTRACT; PLACEBO;

ADULT; ARTICLE; CHEMICAL WARFARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ISOLATION; HUMAN; LUNG FUNCTION TEST; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; WHEEZING;

ADULT; ANTI-ASTHMATIC AGENTS; CHEMICAL WARFARE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; HUMANS; IRAN; LUNG DISEASES; MALE; MIDDLE AGED; MUSTARD GAS; NEBULIZERS AND VAPORIZERS; NIGELLA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY FUNCTION TESTS; SEEDS; TREATMENT OUTCOME;

EID: 57349164816     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0049     Document Type: Article

References (38)

1. Atta UR, Malik SO. Nigellimine N-oxide, a new isoquinoline alkaloid from the seeds of Nigella sativa. Hetrocycles 1985;23:953-955.
2. Atta UR, Malik SO. Nigellidine, a new indazol alkaloid from seeds of Nigella sativa. J Res Inst 1995;36:1993-1996.
3. Ansari AK, Sadiy HAS. Structural studies on a saponin isolated from the seeds of Nigella sativa. Phyto Chem 1989;27:377-379.
4. El-Dakhakhny M. Studies on chemical constitution of Egyptian Nigella sativa L. seeds. II. The essential oil. Plant Med 1963;11:465-470.
5. Labib Salem M. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005;5:1749-1770.
6. Avesina A. Law in Medicine. Interpreter: Sharafkhandy A. Theran Ministry of Guidance Publication, Tehran, Iran: 1990:313-314.
7. Aqel MB. The relaxing effect of volatile oil of Nigella sativa seed on vascular smooth muscle. Jordan Ser B 1992;1:91-100.
8. Aqel MB. Effects of Nigella sativa seeds on intestinal smooth muscle. Inter J Pharmacogn 1993;3:55-60.
9. Reiter M, Brandt W. Relaxant effects on tracheal and ileal smooth muscles of the guinea-pig. Arzneim Forsch Drug Res 1985;35:408-414.
10. Mahfouz M, El-Dakhakhny M. Chemical and pharmacological properties of the new anti-asthmatic drug, nigellone. Egypt Pharm Bull 1960;42:411-424.
11. El-Tahir KEH, Ashour MMS, Al-Harbi MM. The respiratory effect of the volatile oil of the Black seed (Nigella sativa) in guinea pig: Elucidation of the mechanism(s) of action. Gen Pharmacol 1993;24:1115-1122.
12. Boskabady MH, Shahabi M. Bronchodilatory and anticholinergic effects of Nigella sativa on isolated guinea-pig tracheal chains. Iran J Med Sci 1997;22:127-133.
13. Boskabady MH, Shiravi N. Inhibitory effect of Nigella sativa on histamine (H1) receptors of isolated guinea pig tracheal chains. Pharmaceut Biol 2002;40:596-602.
14. Boskabady MH, Shirmohammadi B. Inhibitory effect of Nigella sativa on calcium channels of isolated guinea pig tracheal chains. Arch Ir Med 2002;5:103-107.
15. 2-adrenceptors of guinea pig tracheal chains. Med J Islam Rep Iran 2004;18:153-158.
16. Boskabady MH, Shirmohammadi B, Jandaghi P, Kiani S. Possible mechanisms for relaxant effect of aqueous and macerated extracts from Nigella sativa on tracheal chains of guinea pig. BMC Pharmacol 2004;4:3.
17. Boskabady MH, Kiani S, Jandaghi P, et al. Antitussive of Nigella sativa. Pak J Med Sci 2004;20:224-228.
18. Hajhashemi V, Ghannadi A, Jafarabadi H. Black cumin seed essential oil, as a potent analgesic and anti-inflammatory drug. Phytother Res 2004;18:195-199.
19. Kalus U, Pruss A, Bystron J, et al. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res 2003;17:1209-1214.
20. Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical defense against mustard gas: Toxic mechanics and pharmacological implications. Boca Raton, FL, Ann Arbor, MI, Boston: CRC Press, 1991.
21. Willems JL. Clinical management of mustard gas casualties. Ann Med Milit (Belg) 1989;3(suppl):1-61.
22. Calvet JH, Jarreau PH, Levame M, et al. Acute and chronic effects of sulfur mustard intoxication in the guinea pig. J Appl Physiol 1994;76:681-688.
23. Requena L, Requena C, Sanchez M, et al. Chemical warfare: Cutaneous lesions from mustard gas. J Am Acad Dermatol 1988;19:529-536.
24. Bahadori M, Pishva N, Masjedi MR. History of pulmonary lesions in victims of chemical warfare. Iran J Med Sci 1989;14:999-1005.
25. Evison D, Hinsley D, Rice P. Chemical weapons. Br Med J 2002;324:332-335.
26. Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: Analysis of 197 cases. Chest 1997;112:734-738.
27. Emad A, Rezaian GR, Hoseini K, Ghayyoomi SMA. Chronic pulmonary sequel of sulfur mustard exposure in man: A report of 36 cases. Iran J Med Sci 1995;20:1-4.
28. American Thoracic Society. Standardization of spirometry: 1994 update. Official Statement of American Thoracic Society. Am J Respir Crit Car Med 1995;152:1107-1136.
29. Boskabady MH, Fasihfar M. Correlation between symptom score, reversibility of pulmonary function tests and treatment response in asthma. J Allergy Asthma Immunol 2003;2:61-67.
30. Emad A, Rezaian GR. Immunoglobulins and cellular constituents of the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. Chest 1999;115:1346-1351.
31. Anderson DR, Yourick JJ, Moeller RB, et al. Pathologic changes in rat lungs following acute sulfur mustard inhalation. Inhal Toxicol 1996;8:285-297.
32. Freitag L, Firusian N, Stamatis G, Greschuchna D. The role of bronchoscopy in pulmonary complications due to mustard gas inhalation. Chest 1991;100:1436-1441.
33. Lapa SJR, Ruffie C, Vargaftig BB, et al. Modulation of the bronchial inflammation in sensitized guinea-pigs by FK506, nedocromil sodium and dexamethasone. Eur Respir J 1995;8:1321-1327.
34. Houghton PJ, Zarka R, De las Heras B, Hoult JR. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipidperoxidation. Planta Med 1995;61:33-36.
35. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003;17:299-305.
36. Gilani AH, Aziz N, Khurram IM, et al. Bronchodilator, spasmolytic and calcium antagonistic activities of Nigella sativa seed (Kalonji): A traditional herbal product with multiple medicinal uses. J Pakistan Med Assoc 2001;51:115-20.
37. El-Dakhakhny M, Mady NI, Halim MA. Nigella sativa L. oil protects against induced hepatotoxicity and improves serum lipid profile in rats. Arzneimittelforschung 2000;50:832-836.
38. Mahmoud MR, El-Abhar HS, Saleh S. The effect of Nigella sativa oil against the liver damage induced by Schistosoma mansoni infection in mice. J Ethnopharmacol 2002;79:1-11.